Florida S1552, the Promising Pathways Act, allows experimental treatments for terminal conditions and life-threatening rare diseases under specific.

Florida S1552, the Promising Pathways Act, establishes a framework for the use of experimental treatments for terminal conditions and life-threatening rare diseases. It allows licensed physicians to prescribe and eligible facilities to administer such treatments if certain criteria are met, including patient consent and Institutional Review Board approval. The Department of Health is required to adopt rules for licensing experimental treatment centers and establish a patient registry. Health insurers and health maintenance organizations are encouraged to provide coverage for these treatments.

Florida S1552, the Promising Pathways Act, allows experimental treatments for terminal conditions and life-threatening rare diseases under specific.

Florida S1552, the Promising Pathways Act, establishes a framework for the use of experimental treatments for terminal conditions and life-threatening rare diseases. It allows licensed physicians to prescribe and eligible facilities to administer such treatments if certain criteria are met, including patient consent and Institutional Review Board approval. The Department of Health is required to adopt rules for licensing experimental treatment centers and establish a patient registry. Health insurers and health maintenance organizations are encouraged to provide coverage for these treatments.